CN116868058A - 基于分析物和无细胞血红蛋白浓度确定干扰临界 - Google Patents

基于分析物和无细胞血红蛋白浓度确定干扰临界 Download PDF

Info

Publication number
CN116868058A
CN116868058A CN202180094309.XA CN202180094309A CN116868058A CN 116868058 A CN116868058 A CN 116868058A CN 202180094309 A CN202180094309 A CN 202180094309A CN 116868058 A CN116868058 A CN 116868058A
Authority
CN
China
Prior art keywords
cell
free hemoglobin
concentration
analyte concentration
analyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180094309.XA
Other languages
English (en)
Chinese (zh)
Inventor
M·塔加德
P·弗里绍夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Radiometer Medical ApS
Original Assignee
Radiometer Medical ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radiometer Medical ApS filed Critical Radiometer Medical ApS
Publication of CN116868058A publication Critical patent/CN116868058A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/492—Determining multiple analytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN202180094309.XA 2020-12-22 2021-12-20 基于分析物和无细胞血红蛋白浓度确定干扰临界 Pending CN116868058A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20216633.6 2020-12-22
EP20216633 2020-12-22
PCT/EP2021/086911 WO2022136327A1 (en) 2020-12-22 2021-12-20 Determining interference criticality based on analyte and cell-free hemoglobin concentrations

Publications (1)

Publication Number Publication Date
CN116868058A true CN116868058A (zh) 2023-10-10

Family

ID=73856885

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180094309.XA Pending CN116868058A (zh) 2020-12-22 2021-12-20 基于分析物和无细胞血红蛋白浓度确定干扰临界

Country Status (5)

Country Link
US (1) US20240044918A1 (https=)
EP (1) EP4267972A1 (https=)
JP (2) JP7627348B2 (https=)
CN (1) CN116868058A (https=)
WO (1) WO2022136327A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230333013A1 (en) * 2022-04-15 2023-10-19 Instrumentation Laboratory Co. Fluid testing system

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020012904A1 (en) * 2000-06-09 2002-01-31 Malin Michael J. Automated method for detecting, quantifying and monitoring exogenous hemoglobin in whole blood, plasma and serum
CN102282467A (zh) * 2008-11-13 2011-12-14 贝克曼考尔特公司 对血红蛋白测量的颗粒干扰的校正的方法
WO2017085180A1 (en) * 2015-11-18 2017-05-26 Radiometer Medical Optical sensor for detection of free hemoglobin in a whole blood sample
WO2020033192A1 (en) * 2018-08-06 2020-02-13 Siemens Healthcare Diagnostics Inc. Method and device for determining the concentration of analytes in whole blood

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013012284A (es) * 2011-04-29 2013-11-21 Bristol Myers Squibb Co Regimenes de elevacion de dosis del anticuerpo de proteina 10 inducible por interferon gamma (ip-10).

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020012904A1 (en) * 2000-06-09 2002-01-31 Malin Michael J. Automated method for detecting, quantifying and monitoring exogenous hemoglobin in whole blood, plasma and serum
CN102282467A (zh) * 2008-11-13 2011-12-14 贝克曼考尔特公司 对血红蛋白测量的颗粒干扰的校正的方法
WO2017085180A1 (en) * 2015-11-18 2017-05-26 Radiometer Medical Optical sensor for detection of free hemoglobin in a whole blood sample
CN108463711A (zh) * 2015-11-18 2018-08-28 雷迪奥米特医学公司 用于检测全血样品中的游离血红蛋白的光学传感器
JP2018533011A (ja) * 2015-11-18 2018-11-08 ラジオメーター・メディカル・アー・ペー・エス 流体中の検体を光学的に検出するための多孔質ミラー
WO2020033192A1 (en) * 2018-08-06 2020-02-13 Siemens Healthcare Diagnostics Inc. Method and device for determining the concentration of analytes in whole blood

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
D W JAY 等: "Characterization and mathematical correction of hemolysis interference in selected Hitachi 717 assays", CLIN CHEM, vol. 39, no. 9, 1 October 1993 (1993-10-01) *
DUPUY等: "Determination of hemolysis cut-offs for biochemical and immunochemical analytes according to their value", CLIN CHEM LAB MED, vol. 58, no. 8, 7 April 2020 (2020-04-07), pages 1232 - 1241 *
JAY 等: "Characterization and mathematical correction of hemolysis interference in selected Hitachi 717 assays", CLIN CHEM, vol. 39, no. 9, 30 September 1993 (1993-09-30), pages 1804 - 1810 *
LIPPI 等: "Practical recommendations for managing hemolyzed samples in clinical chemistry testing", CLIN CHEM LAB MED, vol. 56, no. 5, 25 April 2018 (2018-04-25), pages 718 - 727 *

Also Published As

Publication number Publication date
US20240044918A1 (en) 2024-02-08
EP4267972A1 (en) 2023-11-01
WO2022136327A1 (en) 2022-06-30
JP7627348B2 (ja) 2025-02-05
JP2024500231A (ja) 2024-01-05
JP2025069231A (ja) 2025-04-30

Similar Documents

Publication Publication Date Title
Najat Prevalence of pre-analytical errors in clinical chemistry diagnostic labs in Sulaimani city of Iraqi Kurdistan
Kosack et al. Evaluation of the Nova StatSensor® XpressTM creatinine point-of-care handheld analyzer
Smith et al. Toward a framework for outcome-based analytical performance specifications: a methodology review of indirect methods for evaluating the impact of measurement uncertainty on clinical outcomes
CN108572250B (zh) 确定分析物浓度的方法
EP2982979A1 (en) Method for evaluating urine sample, analyzer, and analysis system
Howanitz et al. Practices for identifying and rejecting hemolyzed specimens are highly variable in clinical laboratories
Kos et al. Validation of a new generation POCT glucose device with emphasis on aspects important for glycemic control in the hospital care.
Killilea et al. Blood draw site and analytic device influence hemoglobin measurements
Giles et al. Formula estimation of glomerular filtration rate: have we gone wrong?
Nass et al. Hemoglobin point-of-care testing in rural Gambia: Comparing accuracy of HemoCue and Aptus with an automated hematology analyzer
CA3031081C (en) System and method for optical whole blood hemolysis detection
Loh et al. Setting analytical performance specifications using HbA1c as a model measurand
Kiya et al. Comparison of three-fold converted hematocrit and micro-hematocrit in pregnant women
JP2025069231A (ja) 分析物および無細胞ヘモグロビン濃度に基づく干渉臨界の決定
Weingart et al. Validation of a portable hand‐held whole‐blood ketone meter for use in cats
US20210265028A1 (en) Altering patient care based on long term sdd
Jawa et al. A comparative assessment of the nova stat profile prime plus® critical care analyzer
Westgard et al. Intelligent Quality Management 2 with IntraSpect™ technology for quality control of GEM® Premier™ 5000 blood gas analyzers—A novel application of the patient sample as its own control
Sriram et al. Enhancing anemia diagnostics and accessibility in India: a policy recommendation for effective anemia management
JP2020513218A (ja) 多液品質較正使い捨てカートリッジ
Santos et al. Evaluation of Three Human‐Use Glucometers for Blood Glucose Measurement in Dogs
Sharif-Nia et al. Evaluation of the accuracy, precision, and agreement of a glucometer compared to the standard laboratory test in diabetic and non-diabetic patients
Rojekar et al. Assessment of analytical performance of glucose meter in pediatric age group at tertiary care referral hospital
Yeo et al. Assessing performance of i-STAT at the point of care in the emergency room
CN106990232B (zh) 血液试剂分析系统以及分析方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination